Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Moodys
McKinsey
Harvard Business School
Johnson and Johnson

Last Updated: August 11, 2022

ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Esmolol Hydrochloride In Plastic Container, and when can generic versions of Esmolol Hydrochloride In Plastic Container launch?

Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are two patents protecting this drug.

This drug has seven patent family members in seven countries.

The generic ingredient in ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Esmolol Hydrochloride In Plastic Container

A generic version of ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER was approved as esmolol hydrochloride by HIKMA on August 10th, 2004.

  Try it Free

Summary for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
Drug patent expirations by year for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
Recent Clinical Trials for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chinese Medical AssociationN/A
David N. Proctor, PhDEarly Phase 1
Medical University of ViennaPhase 3

See all ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER clinical trials

Pharmacology for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
Anatomical Therapeutic Chemical (ATC) Classes for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

US Patents and Regulatory Information for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER is protected by two US patents.

Patents protecting ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703-001 Apr 7, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Hq Spclt Pharma ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703-001 Apr 7, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703-001 Apr 7, 2016 See Plans and Pricing See Plans and Pricing
Hq Spclt Pharma ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703-001 Apr 7, 2016 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

See the table below for patents covering ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER around the world.

Country Patent Number Title Estimated Expiration
Brazil 0203517 See Plans and Pricing
Czech Republic 20023825 See Plans and Pricing
Slovakia 12782002 Formulácia esmololu (Esmolol formulation) See Plans and Pricing
European Patent Office 2948379 COMPOSITION PHARMACEUTIQUE DE COSOLVANTS PRÊTE À L'UTILISATION DANS DES RÉCIPIENTS DE MATIÈRE PLASTIQUE FLEXIBLES MODIFIÉS (READY-TO-USE CO-SOLVENTS PHARMACEUTICAL COMPOSITION IN MODIFIED FLEXIBLE PLASTIC CONTAINER) See Plans and Pricing
European Patent Office 1738756 See Plans and Pricing
Israel 151359 ESMOLOL FORMULATION See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Mallinckrodt
Baxter
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.